Acute megakaryoblastic leukemia in Down syndrome
Acute megakaryoblastic leukemia in Down syndrome
复制标题
唐氏综合症急性巨核细胞白血病
作者:
J. Hitzler
Children with Down syndrome (DS) have a 10‐ to 20‐fold increased risk of developing acute leukemia. An estimated 10% of newborns with DS develop Transient Myeloproliferative Disease (TMD) or Transient Leukemia (TL), a clonal accumulation of megakaryoblasts that resolves spontaneously within months. Acute megakaryoblastic leukemia (AMKL) develops in approximately 20% of cases of TMD/TL by 4 years of age. Both the blasts of AMKL and TMD/TL in DS harbor somatic mutations of GATA1, an essential transcriptional regulator of megakaryocytic differentiation. The distinct phenotypes of megakaryoblastic leukemia in DS are a unique biological model of the incremental process of leukemic transformation. Pediatr Blood Cancer 2007;49:1066–1069. © 2007 Wiley‐Liss, Inc.
影响因子:
20.3
作者:
Mundschau, G;Gurbuxani, S;Crispino, JD
通讯作者:
Crispino, JD
影响因子:
20.3
作者:
Taub, JW;Matherly, LH;Ravindranath, Y
通讯作者:
Ravindranath, Y